Back
Evaxion Biotech AS Vs. Novo Nordisk AS Industry Stock Comparison
Sell
28
EVAX
Evaxion Biotech AS
Last Price:
3.05
Seasonality Move:
-23.19%
Sell
43
NVO
Novo Nordisk AS
Last Price:
134.90
Seasonality Move:
4.32%
Sell
28
Evaxion Biotech AS (EVAX)
is a Sell
Is Evaxion Biotech AS a Buy, Sell or Hold?
- The current Evaxion Biotech AS [EVAX] share price is $3.12. The Score for EVAX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- EVAX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
- The current Novo Nordisk AS [NVO] share price is $132.06. The Score for NVO is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- NVO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EVAX Stock Price Chart
What is Evaxion Biotech AS's stock price today?
-
The Evaxion Biotech AS share price today is $3.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVAX is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $132.06
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVO is experiencing slight selling pressure.
EVAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 50.42 | Buy |
Chaikin Money Flow: | 9945 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.01 - 3.31) | Sell |
Bollinger Bands (100): | (2.79 - 3.67) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 46.02 | Sell |
Chaikin Money Flow: | -634415 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (132.57 - 137.25) | Sell |
Bollinger Bands (100): | (129.24 - 140.76) | Sell |
EVAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.13 | Sell |
20-day SMA: | 3.17 | Sell |
50-day SMA: | 3 | Buy |
200-day SMA: | 4.15 | Sell |
8-day EMA: | 3.13 | Sell |
20-day EMA: | 3.12 | Sell |
50-day EMA: | 3.1 | Buy |
200-day EMA: | 4.73 | Sell |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 133.94 | Sell |
20-day SMA: | 134.74 | Sell |
50-day SMA: | 133.59 | Sell |
200-day SMA: | 125.7 | Buy |
8-day EMA: | 133.94 | Sell |
20-day EMA: | 134.12 | Sell |
50-day EMA: | 134.25 | Sell |
200-day EMA: | 124.76 | Buy |
Evaxion Biotech AS Earnings Growth & EVAX Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.83 per share, an increase next quarter of $0.14 per share, an increase this year of $7.50 per share, and a decrease next year of $0.04 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.92 per share.
Evaxion Biotech AS Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |